Cohen Klingenstein’s Emerson Electric EMR Stock Holding History

Cohen Klingenstein’s Portfolio EMR Stock Details EMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.61M	Hold	18,200	–	–	0.07%	109
2026 Q1	$2.38M	Hold	18,200	–	–	0.08%	108
2025 Q4	$2.42M	Hold	18,200	–	–	0.07%	109
2025 Q3	$2.39M	Hold	18,200	–	–	0.07%	103
2025 Q2	$2.43M	Hold	18,200	–	–	0.08%	109
2025 Q1	$2M	Hold	18,200	–	–	0.07%	121
2024 Q4	$2.26M	Hold	18,200	–	–	0.08%	109
2024 Q3	$1.99M	Hold	18,200	–	–	0.07%	128
2024 Q2	$2M	Hold	18,200	–	–	0.07%	128
2024 Q1	$2.06M	Hold	18,200	–	–	0.08%	129
2023 Q4	$1.77M	Hold	18,200	–	–	0.07%	132
2023 Q3	$1.76M	Hold	18,200	–	–	0.08%	127
2023 Q2	$1.65M	Hold	18,200	–	–	0.07%	134
2023 Q1	$1.59M	Hold	18,200	–	–	0.07%	135
2022 Q4	$1.75M	Hold	18,200	–	–	0.09%	128
2022 Q3	$1.33M	Hold	18,200	–	–	0.07%	138
2022 Q2	$1.45M	Hold	18,200	–	–	0.07%	133
2022 Q1	$1.78M	Hold	18,200	–	–	0.07%	127
2021 Q4	$1.69M	Hold	18,200	–	–	0.07%	134
2021 Q3	$1.71M	Hold	18,200	–	–	0.07%	134
2021 Q2	$1.75M	Hold	18,200	–	–	0.08%	138
2021 Q1	$1.64M	Hold	18,200	–	–	0.08%	140
2020 Q4	$1.46M	Hold	18,200	–	–	0.07%	141
2020 Q3	$1.19M	Hold	18,200	–	–	0.07%	146
2020 Q2	$1.13M	Hold	18,200	–	–	0.07%	146
2020 Q1	$867K	Hold	18,200	–	–	0.06%	156
2019 Q4	$1.39M	Hold	18,200	–	–	0.08%	135
2019 Q3	$1.22M	Hold	18,200	–	–	0.08%	140
2019 Q2	$1.21M	Hold	18,200	–	–	0.09%	135
2019 Q1	$1.25M	Hold	18,200	–	–	0.09%	111
2018 Q4	$1.09M	Hold	18,200	–	–	0.16%	88
2018 Q3	$1.39M	Hold	18,200	–	–	0.18%	86
2018 Q2	$1.26M	Hold	18,200	–	–	0.17%	88
2018 Q1	$1.24M	Hold	18,200	–	–	0.18%	89
2017 Q4	$1.27M	Hold	18,200	–	–	0.18%	90
2017 Q3	$1.14M	Hold	18,200	–	–	0.17%	91
2017 Q2	$1.08M	Hold	18,200	–	–	0.17%	91
2017 Q1	$1.09M	Hold	18,200	–	–	0.17%	92
2016 Q4	$1.01M	Hold	18,200	–	–	0.17%	91
2016 Q3	$992K	Hold	18,200	–	–	0.17%	92
2016 Q2	$949K	Hold	18,200	–	–	0.17%	92
2016 Q1	$990K	Hold	18,200	–	–	0.19%	88
2015 Q4	$871K	Hold	18,200	–	–	0.16%	95
2015 Q3	$804K	Sell	18,200 -6,000	-25%	-$295K	0.16%	93
2015 Q2	$1.34M	Hold	24,200	–	–	0.24%	70
2015 Q1	$1.37M	Hold	24,200	–	–	0.25%	64
2014 Q4	$1.49M	Hold	24,200	–	–	0.28%	60
2014 Q3	$1.51M	Hold	24,200	–	–	0.27%	59
2014 Q2	$1.61M	Hold	24,200	–	–	0.31%	54
2014 Q1	$1.62M	Hold	24,200	–	–	0.32%	50
2013 Q4	$1.7M	Hold	24,200	–	–	0.34%	48
2013 Q3	$1.57M	Hold	24,200	–	–	0.34%	48
2013 Q2	$1.32M	Buy	+24,200	New	+$1.36M	0.31%	53

Other funds holding EMR

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

GAM

Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Cohen Klingenstein's EMR Position: Q2 2026 in Review

Cohen Klingenstein held its Emerson Electric (EMR) position steady in Q2 2026 at 18,200 shares worth $2.61M. The position accounts for 0.07% of the portfolio, ranked #109.

Cohen Klingenstein first reported a position in EMR in Q2 2013 and has held it in 53 quarters since. 1,011 funds tracked by Wall St. Rank hold EMR as of Q2 2026.

Cohen Klingenstein held 18,200 shares of Emerson Electric worth $2.61M as of Q2 2026.
Cohen Klingenstein left its Emerson Electric share count unchanged in Q2 2026.
Emerson Electric made up 0.07% of Cohen Klingenstein's portfolio in Q2 2026, its #109 holding.
Cohen Klingenstein first reported a position in Emerson Electric in Q2 2013 and has held it in 53 quarters since.
1,011 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.